Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will bring big reduction in cases
The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will reduce transmission of the disease, perhaps by 50%, resulting in a “dramatic” reduction in cases.
The German company BioNTech and the US pharmaceutical firm Pfizer announced to worldwide acclaim last week that their jointly developed vaccine candidate appeared to be 90% effective in stopping people from falling ill.
